Cell nuclear volume decreases under increasing osmotic pressure. by Adele Khavari (7378082)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…Only introns longer than 50 kb from genes with at least 10 introns are included in these meta-intron profiles, which show the last 50 kb of each aggregated intron. …”

Overexpression of Jagn1 decreases steady-state insulin levels. by Courtney Nosak (1807867)

Acupuncture decreases the level of p-c-Jun after SCI. by Jee Y. Lee (455790)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

Functional Connectivity of the Caudal Anterior Cingulate Cortex Is Decreased in Autism by Yuanyue Zhou (703719)

Selection for West Nile virus populations with decreased susceptibility to ribavirin. by Greta A. Van Slyke (761322)

NE inhibits macrophage migration by decreasing CCR2 expression. by Fangming Xiu (315046)

Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

“…(<b>a</b>) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). (<b>b</b>) Immunostaining analysis 72 hrs after transfection shows that overexpressed Pax6 decreases Olig2 levels in Oli-Neu cells. …”

PR-619 decreases Smad4 expression in UUO mice. by Kotaro Soji (5638613)

Knockout or inhibition of CCR1 decreases peritoneal inflammation and CAIA. by Nuruddeen D. Lewis (192385)

Lethal toxin decreases IL-22 production in human ILCs. by Sudarshan Seshadri (370894)

5-hmC is increased during THP1 macrophage differentiation. by Fangfang Sun (2410654)

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”

Middle Chattahoochee study area with the 2011 NLCD showing point source, calibration gage, and drinking water intake facility locations. by Elly T. Gay (21170097)

Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

The utility of Hmp for NO• consumption and tolerance decreases with increased NO• delivery rate. by Jonathan L. Robinson (409406)

Mother-calf pairs differences among epidermis layers normalized to the mean of all three layers for δ¹³C and δ¹⁵N values. by Michelle Gelippi (9580022)